Arrays Aid Scale-Up Of Drug-Candidate Syntheses | November 24, 2014 Issue - Vol. 92 Issue 47 | Chemical & Engineering News
Volume 92 Issue 47 | p. 7 | News of The Week
Issue Date: November 24, 2014 | Web Date: November 21, 2014

Arrays Aid Scale-Up Of Drug-Candidate Syntheses

Drug Discovery: Researchers optimize syntheses by adapting coupling reactions in array format
Department: Science & Technology
News Channels: Organic SCENE, Materials SCENE
Keywords: Pd, Pd catalysis, coupling reaction, C-N coupling, high-throughput experimentation
[+]Enlarge
The Merck group used arrays of coupling reactions to optimize the microgram-scale C–N coupling of an aryl halide (left) with an amine (over arrow) to give an arylamine. They then scaled up the process to gram level.
The Merck group used arrays of coupling reactions to optimize the microgram-scale C-N coupling of an aryl halide (left) with an amine (over arrow) to give an arylamine. They then scaled up the process to gram level.
 
The Merck group used arrays of coupling reactions to optimize the microgram-scale C–N coupling of an aryl halide (left) with an amine (over arrow) to give an arylamine. They then scaled up the process to gram level.

Coupling reactions are often used to make complex small-molecule drug candidates. But they can be difficult to carry out when starting materials are available in only tiny quantities, as is often the case in natural product synthesis and early stages of drug discovery. Finding the best conditions to scale up syntheses can also be challenging.

Now, researchers have devised an approach that makes it easier to vary reaction conditions and optimize scale-up: running arrays of multiple palladium-catalyzed coupling reactions with small amounts of starting materials. It was developed by chemists Spencer D. Dreher and Tim Cernak, postdocs Alexander Buitrago Santanilla and Erik L. Regalado, and coworkers at Merck Research Laboratories (Science 2014, DOI: 10.1126/science.1259203).

The approach makes it possible to run arrays of Pd-catalyzed C–N, C–O, and C–C coupling reactions on a nanomolar scale with as little as 20 µg of starting materials. The Merck researchers run reaction variations with different catalyst ligands and base reagents and analyze products using liquid chromatography/mass spectrometry. The technique enables them to identify efficient reaction conditions for scale-up.

Adapting these coupling reactions for use in high-throughput arrays was no easy feat. For example, low-boiling-point solvents typically used in coupling reactions are unsuitable for use in small-volume array reactions because they evaporate too quickly. So the Merck researchers run their reactions in a polar, high-boiling-point solvent, dimethylsulfoxide, and use electron-rich ligands to protect the Pd catalyst from DMSO, with which it is normally incompatible. The strong bases generally used in coupling reactions are also incompatible with polar solvents, so the researchers instead use soluble organic “superbases” to activate the reactions in DMSO. The superbases allow the reactions to run at room temperature, providing mild reaction conditions and minimizing solvent loss. And the soluble conditions allow reaction mixtures to be handled by nanoliter liquid-handling robotics for enhanced automation.

The Merck group used the approach to optimize the microgram-scale C–N coupling of a complex aryl halide with an amine to give an arylamine, and then scaled up the reaction to gram level.

“This paper is an eye-popping example of doing chemical synthesis and analysis in a new way—literally orders of magnitude differently than has been done previously,” comments John F. Hartwig of the University of California, Berkeley, an expert in metal-catalyzed coupling reactions. “I never would have thought 20 years ago that C–N coupling could be done on these types of molecules, let alone on the nanomole scale of this work.”

The approach “is potentially transformative, given the extent to which mass limitations have impeded the full deployment of high-throughput experimentation in many contexts, from pharma to academia,” adds University of Ottawa transition-metal catalysis specialist Deryn E. Fogg.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment